Peter Bush

Chief Executive Officer

About

With over 20 years of senior leadership and Board experience, Peter Bush is an executive, investor, mentor and Director, with a focus on the healthcare and technology sectors. Peter has a proven track record of driving growth, innovation, and commercialization in various public and private entities across Australia, USA, Europe, and Asia. He has extensive expertise in mergers and acquisitions, joint ventures, cross border trade, technology licensing, regulatory compliance and risk management. He is also skilled in new business development, venture capital/private equity funding, and technology commercialization. He holds a Bachelor of Commerce from Macquarie University and a Graduate Diploma in Chartered Accounting from the Institute of Chartered Accountants in Australia.

Country

Australia

City

Rose Bay

Industry

Biotechnology

Skill

Analytical Skills, International Sales, Board of Directors, Strategic Partnerships, Growth Capital, Contract Negotiation, Project Management, Forecasting, Budgeting, Investor Relations, Capital Raising, Strategic Financial Management, Financial Analysis, Commercialization, Managerial Finance, Business Valuation, Financial Modeling, Due Diligence, Debt & Equity Capital Raising, Venture Capital

Experience

Chief Executive Officer

ThromBio Holdings

2022-5 - Present · 4 yrs 5 mos

Sydney, New South Wales, Australia

ThromBio Holdings is a clinical stage drug discovery company established in 2020 to commercialise the discoveries of Founder and Scientific Director, Prof. Shaun Jackson. The Company’s mission is to advance the global standard of care for the treatment of stroke using novel anti-thrombotic drugs with unprecedented safety and efficacy. We aim to revolutionise stroke care by focusing on innovative techniques to resume brain blood flow post-stroke, minimizing risks like brain bleeding. Over 30 years in the making, we now have the unique opportunity to commercialise our Australian developed invention - a world first stroke treatment that could influence the global standard of care and help save millions of lives and billions of dollars.

Executive Director

Regional Health Care Group

2007-3 - 2022-12 · 15 yrs 10 mos

Sydney, New South Wales, Australia

Non Executive Director

Vectus Biosystems Limited

2007-5 - 2022-11 · 15 yrs 7 mos

Sydney, New South Wales, Australia

Non-Executive Director Chairman, Audit and Risk Committee

Executive Director

Gryphon Capital

2007-6 - 2022-4 · 14 yrs 11 mos

Sydney, New South Wales, Australia

Gryphon Capital is an independent Australian family office, established to participate in the financing and development of emerging healthcare-related companies.